Drug Pipeline

Sacubitril-valsartan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06536309 Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved… Heart Failure With Preserved Ejection Fraction Not Yet Recruiting
Phase 2/3
NCT04971720 PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis Obesity Recruiting
Phase 1/2
NCT05194111 Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan Heart Failure Recruiting
Sponsors Running Sacubitril-valsartan Trials
University of Alabama at Birmingham (1) Virginia Commonwealth University (1) Brigham and Women's Hospital (1)
Disease Areas
Heart Failure (2) Heart Disease (1) Hypertension (1) Obesity (1)
Get alerts when Sacubitril-valsartan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free